Medical Electronics
Long service life and maximum frequency stability for insulin pumps and CGM systems
By Patricia Schifferdecker, marketing manager, Jauch Quartz GmbH (JQG)
I
n the United Kingdom, around 360,000 people currently suffer from type 1 diabetes. Of these, around 42,000 children and young adults up to the age of 19 are affected. But what does the diagnosis “type 1 diabetes” actually mean? And what do diabetics need to consider after receiving their diagnosis? Which devices and systems help diabetics to manage their daily lives safely? Insulin pumps and CGM systems are such aids. Thanks to high-quality frequency components and long-lasting batteries, they function reliably and enable continuous monitoring and insulin delivery. In the following article, you can find out exactly how these instruments for safe diabetes
16 May 2026
management work and what diabetics need to consider after receiving their diagnosis:
Diagnosis of type 1 diabetes In people with type 1 diabetes, insulin production in the pancreas is impaired: Blood sugar regulation: Insulin is required to transport sugar from the blood into the body’s cells, where it is converted into energy. Without enough insulin, the sugar remains in the blood and leads to increased blood sugar levels. Symptoms and consequences: High blood sugar levels can cause various symptoms, such as frequent urination, a strong feeling of thirst, tiredness, nausea and dizziness. In extreme cases, this can lead to
Components in Electronics
loss of consciousness or a diabetic coma. Treatment: People with type 1 diabetes have to inject insulin every day to regulate their blood sugar levels and avoid complications.
Forms of treatment
Insulin therapy for type 1 diabetes is usually carried out using two main methods: intensified conventional therapy (ICT) and insulin pump therapy (CSII). 1 Intensified conventional therapy (ICT): With ICT, long-acting insulin is injected once or twice a day to cover basic needs. In addition, short-acting insulin is injected before meals to compensate for blood sugar rises after eating or to correct short-term elevated values.
2 Insulin pump therapy (CSII - continuous subcutaneous insulin injection): Insulin pump therapy is also known as continuous subcutaneous insulin injection (CSII). The use of an insulin pump has several advantages, including the elimination of frequent injections of insulin. This therapy uses a small device that is worn on the body and continuously delivers insulin into the subcutaneous fatty tissue. The amount of insulin delivered can be adjusted individually and the user can release additional insulin as required, for example at mealtimes. Insulin pumps can make everyday life easier, especially for people with type 1 diabetes, and are often used in children after diagnosis.
www.cieonline.co.uk
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
